1. Home
  2. ARWR vs VTMX Comparison

ARWR vs VTMX Comparison

Compare ARWR & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • VTMX
  • Stock Information
  • Founded
  • ARWR 2003
  • VTMX 1998
  • Country
  • ARWR United States
  • VTMX Mexico
  • Employees
  • ARWR N/A
  • VTMX N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • VTMX
  • Sector
  • ARWR Health Care
  • VTMX
  • Exchange
  • ARWR Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • ARWR 2.6B
  • VTMX 2.2B
  • IPO Year
  • ARWR 1993
  • VTMX 2023
  • Fundamental
  • Price
  • ARWR $19.90
  • VTMX $24.46
  • Analyst Decision
  • ARWR Buy
  • VTMX Buy
  • Analyst Count
  • ARWR 11
  • VTMX 2
  • Target Price
  • ARWR $43.33
  • VTMX $33.50
  • AVG Volume (30 Days)
  • ARWR 2.5M
  • VTMX 243.1K
  • Earning Date
  • ARWR 02-10-2025
  • VTMX 02-18-2025
  • Dividend Yield
  • ARWR N/A
  • VTMX 2.88%
  • EPS Growth
  • ARWR N/A
  • VTMX N/A
  • EPS
  • ARWR N/A
  • VTMX 0.25
  • Revenue
  • ARWR $2,500,000.00
  • VTMX $252,327,122.00
  • Revenue This Year
  • ARWR $3,336.78
  • VTMX N/A
  • Revenue Next Year
  • ARWR $124.29
  • VTMX $9.13
  • P/E Ratio
  • ARWR N/A
  • VTMX $9.26
  • Revenue Growth
  • ARWR N/A
  • VTMX 17.65
  • 52 Week Low
  • ARWR $17.05
  • VTMX $23.22
  • 52 Week High
  • ARWR $36.72
  • VTMX $41.44
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 49.40
  • VTMX 37.01
  • Support Level
  • ARWR $17.57
  • VTMX $24.28
  • Resistance Level
  • ARWR $21.84
  • VTMX $27.24
  • Average True Range (ATR)
  • ARWR 1.06
  • VTMX 0.86
  • MACD
  • ARWR 0.11
  • VTMX -0.25
  • Stochastic Oscillator
  • ARWR 54.57
  • VTMX 5.10

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: